SCLP — Scancell Holdings Share News
0.000.00%
Last trade - 00:00- £112.74m
- £121.25m
Scancell Hlds - Second Commercial License Agreement with Genmab
Scancell Hlds - Holding(s) in Company
Brief: Scancell Holdings Says Dr Phil L’Huillier to takeover as CEO
Scancell Hlds - Scancell Appoints Dr Phil L’Huillier as CEO
Scancell Hlds - Notice of AGM
Scancell Hlds - Results Year Ended 30 April 2024
Scancell Hlds - Notice of Final Results
Brief: Scancell Holdings Signs Strategic Partnership With PharmaJet
Scancell Hlds - Strategic Partnership with PharmaJet
Brief: Scancell Continues To Recruit To Scope Study, Which Includes Patients Treated With Scib1 As Well As iSCIB1+
Scancell Hlds - Update from iSCIB1+ Clinical Advisory Meeting
Scancell Hlds - Appointment of Dr Florian Reinaud to the Board
Brief: Scancell Signs Agreement With Biotech Co To Evaluate Antibody In Glymab® Portfolio
Scancell Hlds - Agreement with major biotech
Brief: Scancell Holdings Receives MHRA Approval To Expand Modify Trial
Scancell Hlds - Issue of share options
Scancell Hlds - Employee exercise of share options
Scancell Hlds - First iSCIB1+ patient dosed
Scancell Hlds - Appointment of Sath Nirmalananthan to the Board